147 related articles for article (PubMed ID: 36957981)
21. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
22. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
Patwa SA; Ward C; Kelly CR
R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
[TBL] [Abstract][Full Text] [Related]
23. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
Cappetto CM
Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
[TBL] [Abstract][Full Text] [Related]
24. Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.
Gilca-Blanariu GE; Stefanescu G; Girleanu I; Iqbal T; Segal J; Mullish B; Quraishi MN; Keller J; Molnar T; Megraud F; Dumitrascu D; Manuc M; Iancu LS; Marica C; Gheorghe C; Manzoor S; Trifan A
J Gastrointestin Liver Dis; 2021 Mar; 30(1):147-163. PubMed ID: 33723543
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient presenting with hypertensive disorder post interventionem.
Goeser F; Schlabe S; Ruiner CE; Kramer L; Strassburg CP; Spengler U
Z Gastroenterol; 2016 Oct; 54(10):1143-1146. PubMed ID: 27644000
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection.
Gupta S; Zhu J; McCarty TR; Pruce J; Kassam Z; Kelly C; Fischer M; Allegretti JR
J Gastroenterol Hepatol; 2021 Sep; 36(9):2432-2440. PubMed ID: 33682170
[TBL] [Abstract][Full Text] [Related]
27. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome.
Gotoh K; Sakaguchi Y; Kato H; Osaki H; Jodai Y; Wakuda M; Také A; Hayashi S; Morita E; Sugie T; Ito Y; Ohmiya N
Anaerobe; 2022 Feb; 73():102502. PubMed ID: 34896553
[TBL] [Abstract][Full Text] [Related]
28. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
[TBL] [Abstract][Full Text] [Related]
29. Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study.
Gweon TG; Lee YJ; Yim SK; Kim SY; Choi CH; Cho YS;
Korean J Intern Med; 2023 Jan; 38(1):48-55. PubMed ID: 36353787
[TBL] [Abstract][Full Text] [Related]
30. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
[TBL] [Abstract][Full Text] [Related]
31. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
32. Microbiota or placebo after antimicrobial therapy for recurrent
Drekonja DM; Shaukat A; Zhang JH; Reinink AR; Nugent S; Dominitz JA; Davis-Karim A; Gerding DN; Kyriakides TC
Clin Trials; 2021 Oct; 18(5):622-629. PubMed ID: 34154439
[TBL] [Abstract][Full Text] [Related]
33. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
[TBL] [Abstract][Full Text] [Related]
34. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection.
Kim KO; Schwartz MA; Lin OST; Chiorean MV; Gluck M
Adv Ther; 2019 Aug; 36(8):2052-2061. PubMed ID: 31154629
[TBL] [Abstract][Full Text] [Related]
35. Does Fecal Microbiota Transplant Have a Role in Treating Recurrent
Vedala K; Sobash P; Shah P; Kamoga GR
Front Public Health; 2021; 9():670941. PubMed ID: 34178927
[No Abstract] [Full Text] [Related]
36. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
Orenstein R; Dubberke ER; Khanna S; Lee CH; Yoho D; Johnson S; Hecht G; DuPont HL; Gerding DN; Blount KF; Mische S; Harvey A
BMC Infect Dis; 2022 Mar; 22(1):245. PubMed ID: 35279084
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis.
Pomares Bascuñana RÁ; Veses V; Sheth CC
Lett Appl Microbiol; 2021 Aug; 73(2):149-158. PubMed ID: 33864273
[TBL] [Abstract][Full Text] [Related]
38. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
[TBL] [Abstract][Full Text] [Related]
39. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
40. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L
Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
